Skip to main content
    X

    XBiotech Inc (XBIT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.85
    -0.11 (-5.61%)

    Market Cap: $59.76M

    Last updated: Nov 17, 2026 at 11:01 AM ET

    XBiotech Inc (XBIT) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to XBiotech are Connect Biopharma Holdings (CNTB), iBio, Inc. Common Stock (IBIO) and Actinium Pharmaceuticals (ATNM). By market cap, XBiotech ranks 3rd of the 13 companies on this page; Anixa Biosciences (ANIX) is the largest at $91.08M.

    Peer Comparison

    XBIT's revenue growth of -93.3% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    XBiotech (XBIT)$59.76MN/AN/A0.0%N/A-93.3%0.00%
    Connect Biopharma Holdings Ltd (CNTB)$42.65MN/A13.6x0.0%N/A5667.0%0.00%
    iBio, Inc. Common Stock (IBIO)$51.55MN/A735.4x0.0%N/A975.0%0.00%
    Actinium Pharmaceuticals Inc (ATNM)$51.56M4.1x1.3x32.2%N/A-100.0%0.00%
    Anixa Biosciences Inc (ANIX)$91.08MN/AN/A0.0%N/A0.0%0.00%
    Oncolytics Biotech Inc (ONCY)$48.51MN/AN/A0.0%N/A0.0%0.00%
    Gain Therapeutics Inc (GANX)$46.31MN/AN/A0.0%-170.5%-100.0%0.00%
    ImageneBio, Inc. (IMA)$43.22MN/A68.5x0.0%N/A0.0%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    Mink Therapeutics Inc (INKT)$47.95MN/A236.3x0.0%N/A0.0%0.00%
    Biomea Fusion Inc (BMEA)$42.31MN/AN/A0.0%N/A0.0%0.00%
    Werewolf Therapeutics Inc (HOWL)$47.64MN/A2.3x-164.8%N/A-100.0%0.00%
    vTv Therapeutics Inc (VTVT)$78.99MN/AN/A-20.8%N/A0.0%0.00%
    Peer median$47.79M4.1x13.6x0.0%-499.1%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to XBiotech, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Connect Biopharma Holdings Ltd (CNTB)
    Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators...
    CNTB competitors
    iBio, Inc. Common Stock (IBIO)
    iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States.
    IBIO competitors
    Actinium Pharmaceuticals Inc (ATNM)
    Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation...
    ATNM competitors
    Anixa Biosciences Inc (ANIX)
    Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases.
    ANIX competitors
    Oncolytics Biotech Inc (ONCY)
    Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer.
    ONCY competitors
    Gain Therapeutics Inc (GANX)
    Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding.
    GANX competitors
    ImageneBio, Inc. (IMA)
    ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases.
    IMA competitors
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    Mink Therapeutics Inc (INKT)
    MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic...
    INKT competitors
    Biomea Fusion Inc (BMEA)
    Biomea Fusion, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of irreversible small molecules to treat...
    BMEA competitors
    Werewolf Therapeutics Inc (HOWL)
    Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapies designed to boost the body's immune system for the treatment of cancer.
    HOWL competitors
    vTv Therapeutics Inc (VTVT)
    vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet...
    VTVT competitors

    Frequently Asked Questions About XBIT

    Who are XBiotech's main competitors?

    The companies most similar to XBiotech include Connect Biopharma Holdings (CNTB), iBio, Inc. Common Stock (IBIO), Actinium Pharmaceuticals (ATNM), Anixa Biosciences (ANIX) and Oncolytics Biotech (ONCY), listed from the closest match.

    Who is XBiotech's biggest competitor?

    Anixa Biosciences (ANIX) is the largest of the similar companies at $91.08M; Connect Biopharma Holdings (CNTB) is the closest match by business profile, size, sector and industry.

    How does XBIT stock compare with its competitors?

    XBIT's net margin is 0.0% against a peer median of 0.0%.

    Which of XBiotech's competitors pays a higher dividend?

    XBiotech pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is XBiotech bigger than its competitors?

    No. XBiotech is 3rd by market cap among the 13 companies on this page; the largest is Anixa Biosciences (ANIX) at $91.08M.